Factors Associated with Pneumococcal Vaccination in 2040 People with Type 2 Diabetes: A Cross-sectional Study.

CONCLUSION: Based on this information, future programs aimed at people aged < 65 years old, men, those who are currently working, those recently diagnosed with diabetes, and those with few comorbidities could have the most potential for improving pneumococcal vaccine uptake in people with diabetes. PMID: 31255692 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31255692?dopt=Abstract

Source: Diabetes and Metabolism - June 26, 2019 Category: Endocrinology Authors: Gilani F, Majumdar SR, Johnson JA, Simpson SH, ABCD Cohort Investigators Tags: Diabetes Metab Source Type: research